ARIAD and Bellicum Announce Revised License Agreement for ARIAD's Cell-Signaling Technology CAMBRIDGE, Mass. & HOUSTON-- --ARIAD Pharmaceuticals, Inc. and Bellicum Pharmaceuticals, Inc. today announced a restructuring of their license agreement for ARIAD's cell-signaling technology.
http://ift.tt/1xVEUW4
http://ift.tt/1xVEUW4
No comments:
Post a Comment